Five of the most common regulatory pitfalls—and how to avoid them before they derail your IVD program.
Even strong IVD programs can collapse under regulatory pressure. In this episode, DCN Dx unpacks the preventable risks that lead to delayed submissions, costly rework, and missed approvals. You’ll hear the real reasons protocols fall short—and how to build alignment across clinical, regulatory, and usability workstreams from the start. If you’re working toward FDA or global approval, this conversation will help you stay ahead of the most common points of failure.
Why Listen:
- Understand how vague intended use leads to regulatory red flags
- Learn when and how to use the FDA Pre-Submission process effectively
- Avoid mismatches between study endpoints and label claims
- Get ahead of usability and human factors requirements before they block your launch
- Discover how tight data management practices protect your credibility during review
